Colorectal Completed Projects |
click here for more details on the projects
- Development of personalised medicine approaches for the clinical application of IAP antagonists in metastatic and high risk early stage colorectal cancer SFI
- A systems-based patient stratification tool of Bcl-2 family protein interactions to evaluate acute treatment responses in rectal cancer patients
- BCL-2 family proteins and cellular bioenergetics in the control of cell survival: Towards novel predictive and prognostic markers for disease progression and therapy responses in colorectal cancer patients
- HRB Translational Award: APO-COLON: Qualitative and quantitative analysis of factors contributing to apoptosis resistance in colorectal cancer: Evaluation of new prognostic and therapeutic avenues
- HRB Patient-Oriented Research Award: Pro-caspase -3 as a Biomarker for Treatment Responses in Colorectal Cancer
- HRB Patient-Oriented Research Award: Serum Biomarkers in Colorectal Cancer